These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

105 related items for PubMed ID: 998692

  • 41. Combined phacoemulsification, intraocular lens implantation, and vitrectomy for eyes with coexisting cataract and vitreoretinal pathology.
    Demetriades AM, Gottsch JD, Thomsen R, Azab A, Stark WJ, Campochiaro PA, de Juan E, Haller JA.
    Am J Ophthalmol; 2003 Mar; 135(3):291-6. PubMed ID: 12614744
    [Abstract] [Full Text] [Related]

  • 42. Ultra-widefield imaging of golden vitreous membranes requiring pars plana vitrectomy in a case of chronic ocular chalcosis.
    Sundar MD, Ayyadurai N, Chawla R, Hasan N.
    Indian J Ophthalmol; 2019 Nov; 67(11):1878-1879. PubMed ID: 31638056
    [No Abstract] [Full Text] [Related]

  • 43.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 44. Isolated vitreoretinal amyloidosis in the absence of transthyretin mutations.
    Barouch FC, Benson MD, Mukai S.
    Arch Ophthalmol; 2004 Jan; 122(1):123-5. PubMed ID: 14718311
    [No Abstract] [Full Text] [Related]

  • 45.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 46.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 47. Pars plana vitrectomy for visually disturbing vitreous floaters in pseudophacic eyes.
    Stoffelns BM, Vetter J, Keicher A, Mirshahi A.
    Klin Monbl Augenheilkd; 2011 Apr; 228(4):293-7. PubMed ID: 21484632
    [Abstract] [Full Text] [Related]

  • 48. Bilateral optic neuropathy and intraretinal deposits after pars plana vitrectomy in amyloidosis.
    Rossetti A, Spedicato L, Fassina A, Doro D.
    Indian J Ophthalmol; 2015 Jan; 63(1):72-4. PubMed ID: 25686071
    [Abstract] [Full Text] [Related]

  • 49. The vitrophage in ocular reconstruction following trauma.
    Peyman GA, Diamond JG.
    Can J Ophthalmol; 1975 Jul; 10(3):419-22. PubMed ID: 1148914
    [Abstract] [Full Text] [Related]

  • 50.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 51.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 52. [Efficacy of intravitreal triamcinolone acetonide in the visualization of the vitreous during pars plana vitrectomy].
    Mańkowska A, Rejdak R, Nowomiejska K, Zagórski Z.
    Klin Oczna; 2006 Jul; 108(1-3):24-7. PubMed ID: 16883934
    [Abstract] [Full Text] [Related]

  • 53.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 54.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 55.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 56. Pars plana vitrectomy. Vitrectomy treatment of vitreous opacities.
    Peyman GA, Huamonte FU, Goldberg MF.
    Trans Sect Ophthalmol Am Acad Ophthalmol Otolaryngol; 1976 Jul; 81(3 Pt 1):394-8. PubMed ID: 960361
    [Abstract] [Full Text] [Related]

  • 57.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 58.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 59. Amyloidosis of the vitreous. Fluorescein angiographic findings and association with neovascularization.
    Savage DJ, Mango CA, Streeten BW.
    Arch Ophthalmol; 1982 Nov; 100(11):1776-9. PubMed ID: 6182867
    [Abstract] [Full Text] [Related]

  • 60.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.